Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 91 tables and 94 figures, this 185-page report 鈥淕lobal Organ Transplant Diagnostics 麻豆原创 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments
鈥� Test Kits & Consumables
o Kits & Assays
o Consumables
鈥� Software & Services
Based on Transplant, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
鈥� Stem Cell Transplant
鈥� Soft Tissue Transplant
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Diagnostics
o Donor Testing
o Recipient Testing
鈥� Translational Research
By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
鈥� Serology
鈥� Flow Cytometry
鈥� Other Technologies
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals and Transplant Centers
鈥� Reference Laboratories
鈥� Academic and Research Institutions
鈥� Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
鈥� North America (U.S., Canada, and Mexico)
鈥� Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
鈥� APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
鈥� South America (Brazil, Chile, Argentina, Rest of South America)
鈥� MEA (UAE锛孲audi Arabia锛� South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioM茅rieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of 麻豆原创 Research Methodology 13
1.2.2 麻豆原创 Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 麻豆原创 Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 麻豆原创 Overview and Dynamics 21
2.1 麻豆原创 Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 26
2.2 Major Growth Drivers 28
2.3 麻豆原创 Restraints and Challenges 34
2.4 Emerging Opportunities and 麻豆原创 Trends 37
2.5 Porter鈥檚 Fiver Forces Analysis 41
3 Segmentation of Global 麻豆原创 by Offering 45
3.1 麻豆原创 Overview by Offering 45
3.2 Instruments 47
3.3 Test Kits & Consumables 49
3.3.1 Kits & Assays 50
3.3.2 Consumables 52
3.4 Software & Services 54
4 Segmentation of Global 麻豆原创 by Transplant 56
4.1 麻豆原创 Overview by Transplant 56
4.2 Solid Organ Transplant 58
4.2.1 Kidney 60
4.2.2 Liver 61
4.2.3 Heart 62
4.2.4 Lung 63
4.2.5 Pancreas 64
4.2.6 Kidney-Pancreas 65
4.2.7 Other Solid Organ Transplants 66
4.3 Stem Cell Transplant 67
4.4 Soft Tissue Transplant 68
5 Segmentation of Global 麻豆原创 by Application 69
5.1 麻豆原创 Overview by Application 69
5.2 Diagnostics 71
5.2.1 Donor Testing 72
5.2.2 Recipient Testing 73
5.3 Translational Research 74
6 Segmentation of Global 麻豆原创 by Technology 75
6.1 麻豆原创 Overview by Technology 75
6.2 Molecular Technologies 77
6.2.1 PCR 79
6.2.2 Sequencing 80
6.2.3 Other Molecular Technologies 81
6.3 Serology 82
6.4 Flow Cytometry 83
6.5 Other Technologies 84
7 Segmentation of Global 麻豆原创 by End User 85
7.1 麻豆原创 Overview by End User 85
7.2 Hospitals and Transplant Centers 87
7.3 Reference Laboratories 88
7.4 Academic and Research Institutions 89
7.5 Other End Users 90
8 Segmentation of Global 麻豆原创 by Region 91
8.1 Geographic 麻豆原创 Overview 2021-2031 91
8.2 North America 麻豆原创 2021-2031 by Country 95
8.2.1 Overview of North America 麻豆原创 95
8.2.2 U.S. 99
8.2.3 Canada 102
8.2.4 Mexico 104
8.3 European 麻豆原创 2021-2031 by Country 106
8.3.1 Overview of European 麻豆原创 106
8.3.2 Germany 110
8.3.3 U.K. 112
8.3.4 France 114
8.3.5 Spain 116
8.3.6 Italy 118
8.3.7 Netherlands 120
8.3.8 Rest of European 麻豆原创 122
8.4 Asia-Pacific 麻豆原创 2021-2031 by Country 124
8.4.1 Overview of Asia-Pacific 麻豆原创 124
8.4.2 Japan 128
8.4.3 China 131
8.4.4 Australia 133
8.4.5 India 135
8.4.6 South Korea 137
8.4.7 Rest of APAC Region 139
8.5 South America 麻豆原创 2021-2031 by Country 141
8.5.1 Argentina 144
8.5.2 Brazil 146
8.5.3 Chile 148
8.5.4 Rest of South America 麻豆原创 150
8.6 MEA 麻豆原创 2021-2031 by Country 151
8.6.1 UAE 154
8.6.2 Saudi Arabia 156
8.6.3 South Africa 158
8.6.4 Other National 麻豆原创s 160
9 Competitive Landscape 161
9.1 Overview of Key Vendors 161
9.2 New Product Launch, Partnership, Investment, and M&A 165
9.3 Company Profiles 166
Abbott Laboratories Inc. 166
ARUP Laboratories 168
BAG Health Care GmbH 169
Becton Dickinson and Company 170
bioM茅rieux S.A. 171
Bio-Rad Laboratories, Inc. 172
CareDx, Inc. 173
Eurofins Scientific 174
F. Hoffmann-La Roche Ltd. 175
Illumina, Inc. 176
Immucor, Inc. 177
Laboratory Corporation of America Holdings 178
Novacyt Group 179
Omixon Ltd. 180
OPKO Health 181
QIAGEN N.V. 182
Quest Diagnostics Incorporated 183
Thermo Fisher Scientific Inc. 184
RELATED REPORTS 185
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioM茅rieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
